A comparison of the acute hemodynamic effects of inhaled nitric oxide and aerosolized iloprost in primary pulmonary hypertension
Journal of the American College of CardiologyPublished 1 January 2000
Marius M. Hoeper, Horst Olschewski, Hossein Ardeschir Ghofrani, Heinrike Wilkens, J Winkler, Mathias M. Borst
Citations316
SJR quartileQ1
SJR score9.02
SNIP6.30
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
During acute drug testing, aerosolized iloprost was more potent than inhaled NO as a pulmonary vasodilator in PPH at the doses used in this study.
Abstract
During acute drug testing, aerosolized iloprost was more potent than inhaled NO as a pulmonary vasodilator in PPH at the doses used in this study.
Keywords
Medicine
New England Journal of MedicineA Comparison of Continuous Intravenous Epoprostenol (Prostacyclin) with Conventional Therapy for Primary Pulmonary Hypertension
2,678 Citations1996Robyn J. Barst, Lewis J. Rubin +18 more
As compared with conventional therapy, the continuous intravenous infusion of epoprostenol produced symptomatic and hemodynamic improvement, as well as improved survival in patients with severe primary pulmonary hypertension.
Annals of Internal MedicinePrimary Pulmonary Hypertension
2,039 Citations1987Stuart Rich, DAVID R. DANTZKER +12 more
Although no deaths or sustained morbid events occurred during the diagnostic evaluation of the patients, the typically long interval from initial symptoms to diagnosis emphasizes the need to develop strategies to make the diagnosis earlier.
New England Journal of MedicinePrimary Pulmonary Hypertension
1,727 Citations1997Lewis J. Rubin
Qualitative histologic examination of lung tissue did not provide a basis for predicting how individual patients would respond to vasodilator agents, but quantitative morphologic analysis of the initial open lung biopsy specimens did prove helpful in predicting acute responsiveness to vasodermal agents and the subsequent clinical course of these patients with unexplained (primary) pulmonary hypertension.
CirculationInhaled nitric oxide. A selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction.
1,136 Citations1991Claes Frostell, M D Fratacci +3 more
Breathing 80 ppm NO for 3 hours did not increase either methemoglobin or extravascular lung water levels or modify lung histology compared with those in control lambs.
The LancetInhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertension
1,047 Citations1991Joanna Pepke‐Żaba
Although SVR fell substantially after prostacyclin in patients with pulmonary hypertension, inhaled NO had no effect on SVR in any patient or volunteer, and seems to be both a selective and effective pulmonary vasodilator.
Annals of Internal MedicineTreatment of Primary Pulmonary Hypertension with Continuous Intravenous Prostacyclin (Epoprostenol)
703 Citations1990Lewis J. Rubin, Jessica Mendoza +7 more
Prostacyclin produces substantial and sustained hemodynamic and symptomatic responses in severe primary pulmonary hypertension and may be useful in the management of some patients with this disease.
New England Journal of MedicineReduction in Pulmonary Vascular Resistance with Long-Term Epoprostenol (Prostacyclin) Therapy in Primary Pulmonary Hypertension
668 Citations1998Vallerie V. McLaughlin, Diane Genthner +2 more
In primary pulmonary hypertension, long-term therapy with epoprostenol lowers pulmonary vascular resistance beyond the level achieved in the short term with intravenous adenosine.
Annals of Internal MedicineSurvival in Primary Pulmonary Hypertension with Long-Term Continuous Intravenous Prostacyclin
553 Citations1994Robyn J. Barst, Lewis J. Rubin +4 more
The objective of this study was to evaluate the effects of long-term intravenous infusion of prostacyclin on exercise capacity, hemodynamics, and survival in patients with primary pulmonary hypertension.
Annals of Internal MedicineAerosolized Prostacyclin and Iloprost in Severe Pulmonary Hypertension
388 Citations1996Horst Olschewski, Dieter Walmrath +4 more
This strategy was extended by nebulizing prostacyclin and a stable analog, iloprost, in patients with severe pulmonary hypertension, and achieved selective pulmonary vasodilatation with a concomitant improvement of ventilation-perfusion matching in mechanically ventilated patients with the adult respiratory distress syndrome.
The LancetLONG-TERM TREATMENT OF PRIMARY PULMONARY HYPERTENSION WITH CONTINUOUS INTRAVENOUS EPOPROSTENOL (PROSTACYCLIN)
323 Citations1984Tim Higenbottam, Frank C. Wells +2 more
A young woman, bedbound with severe pulmonary hypertension, responded to intravenous epoprostenol with a fall in pulmonary vascular resistance, improved oxygenation, and a rise in exercise tolerance.
CirculationEffects of Long-term Infusion of Prostacyclin (Epoprostenol) on Echocardiographic Measures of Right Ventricular Structure and Function in Primary Pulmonary Hypertension
318 Citations1997Alan L. Hinderliter, Park W. Willis +21 more
The echocardiographic characteristics of participants in this trial; the relationships of echOCardiographic variables to hemodynamic parameters, exercise capacity, and quality of life; and the echoprostenol changes associated with prostacyclin therapy are described.
American Journal of Respiratory and Critical Care MedicineInhaled Nitric Oxide as a Screening Vasodilator Agent in Primary Pulmonary Hypertension. A Dose-Response Study and Comparison with Prostacyclin
317 Citations1995Olivier Sitbon, F Brénot +7 more
Inhaled NO at low dose (10 ppm) appears to be an effective, safe, and reliable substitute for PGI2 in screening for acute pulmonary vasodilator responsiveness during therapeutic assessment of patients with PPH.
Journal of the American College of CardiologyPrimary Pulmonary Hypertension: Improved Long-Term Effects and Survival With Continuous Intravenous Epoprostenol Infusion
307 Citations1997Shelley Shapiro, Ronald J. Oudiz +7 more
Long-term follow-up of this single-center patient group demonstrated improved long-term survival during epo therapy compared with that in historical control subjects and confirms predicted improved outcomes based on shorter follow- up periods.
American Journal of Respiratory Cell and Molecular BiologyProstaglandins Induce Vascular Endothelial Growth Factor in a Human Monocytic Cell Line and Rat Lungs via cAMP
128 Citations1997Marius M. Höper, Norbert F. Voelkel +5 more
The data suggest that prostaglandins stimulate VEGF gene expression in monocytic cells and in rat lungs via a cAMP-dependent mechanism.
CirculationClinical Significance of the Pulmonary Vasodilator Response During Short-term Infusion of Prostacyclin in Primary Pulmonary Hypertension
121 Citations1996Olivier Raffy, R. Azarian +8 more
Patients with PPH exhibiting a decrease in TPRi > 50% during short-term PGI2 challenge at the time of diagnosis had longer disease evolutions and better prognoses than patients with a lower vasodilator response.
Journal of the American College of CardiologyInhaled nitric oxide in primary pulmonary hypertension
119 Citations1998Mark J. Ricciardi, Bradley P. Knight +2 more
The pulmonary vascular response to inhaled NO accurately predicts the acute hemodynamic response to nifedipine in PPH, and a positive response to NO is associated with a safe nifingipine trial.
Réanimation UrgencesInhaled nitric oxide as a screening vasodilator agent in primary pulmonary hypertension
109 Citations1996Olivier Sitbon, F Brénot +7 more
In 35 consecutive patients with primary pulmonary hypertension, the hemodynamic effects of incremental inhalation periods of an air-NO mixture at different concentrations and compared them to those of an acute infusion of prostacyclin (PGI2) were examined.
Prostacyclin and Its Stable Analogue Iloprost
96 Citations1987R.J. Gryglewski, G. Stock
American Journal of Respiratory and Critical Care MedicineInhaled Nitric Oxide Used as a Bridge to Heart-Lung Transplantation in a Patient with End-Stage Pulmonary Hypertension
80 Citations1995Gregory I. Snell, Robert F. Salamonsen +4 more
A 40-yr-old woman who received inhaled nitric oxide as a therapeutic bridge to heart-lung transplantation for end-stage primary pulmonary hypertension is described, with the recurrence of severe symptoms and hemodynamic compromise.
Intensive Care MedicineRecovery from circulatory shock in severe primary pulmonary hypertension (PPH) with aerosolization of iloprost
67 Citations1998Horst Olschewski, Hossein Ardeschir Ghofrani +4 more
Inhalation of aerosolized iloprost may offer a new life-saving strategy in near desperate cases of pulmonary hypertension in which intravenous prostacyclin cannot be applied due to severe side effects.
The LancetCaution with use of inhaled nitric oxide
62 Citations1996JB Warren, Tim Higenbottam
There remains uncertainty about the effects of inhaled-NO on gas exchange because, unlike what happens in ARDS, when given to chronic obstructive lung disease patients, it causes a fall in arterial oxygen tension.
PubMedMyocardial performance is modulated by interaction of cardiac endothelium derived nitric oxide and prostaglandins.
59 Citations1995Puneet Mohan, Dirk L. Brutsaert +1 more
American Journal of Physiology-Endocrinology and MetabolismRole of cAMP and calcium influx in endothelin-1-induced ANP release in rat cardiomyocytes
38 Citations1997M. Rebsamen, Dennis Church +3 more
The results suggest that ET-1 stimulates ANP release in ventricular cardiomyocytes via an ETAreceptor-mediated pathway involving cAMP formation and activation of a nifedipine-sensitive calcium channel.
The FASEB JournalNitric oxide‐related vasoconstriction in lungs perfused with red cell lysate
35 Citations1995N. F. Voelkel, K. Lobel +2 more
The data indicate that hemolysate has profound effects on lung vessel tone regulation and on lung tissue mitochondrial function, yet the precise molecular mechanisms responsible for the action of hemolySate are likely to be very complex.
ThoraxNitric oxide and prostacyclin as test agents of vasoreactivity in severe precapillary pulmonary hypertension: predictive ability and consequences on haemodynamics and gas exchange
35 Citations1997P. Jolliet, Pierre Bulpa +3 more
No inhalation can accurately predict a vasodilator response to nifedipine in patients with severe pulmonary hypertension without adverse effects on systemic haemodynamics and gas exchange.
Chemistry of Stable Prostacyclin Analogues: Synthesis of Iloprost
24 Citations1987Werner Skuballa, Bernd Radüchel +1 more
The discovery of prostacyclin and its potent inhibitory action on platelet aggregation in 1976 has not only revolutionized concepts in cardiovascular research but has also made this important molecule a target for intensive biological and chemical research.
Prostacyclin and Iloprost — Thrombosis and Atherosclerosis
2 Citations1987H. Sinzinger
Since the discovery of prostacyclin in 1976, its extremely potent action on the platelets has been the focus of research, based upon the finding that atherosclerotic vascular walls generate less PGI2 than normal ones.